Cargando…

The In Vitro Activity of Fluconazole, Amphotericin B and Echinocandins Against Cyberlindnera fabianii Planktonic Cells and Biofilms

Until recently, little was known about the susceptibility pattern of Cyberlindnera fabianii (Cy. fabianii) planktonic cells and biofilms regarding the most frequently administered systemic antifungals, despite the high mortality rate and its potential role in catheter-related infections. In the curr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tóth, Zoltán, Bozó, Aliz, Kovács, Renátó, Balogh, Bettina, Balázs, Bence, Forgács, Lajos, Kelentey, Barna, Majoros, László
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169879/ https://www.ncbi.nlm.nih.gov/pubmed/36399230 http://dx.doi.org/10.1007/s11046-022-00688-9

Ejemplares similares

Genome Sequence of the Yeast Cyberlindnera fabianii (Hansenula fabianii)
por: Freel, Kelle C., et al.
Publicado: (2014)

Identification and Antifungal Susceptibility Profiles of Cyberlindnera fabianii in Korea
por: Park, Ji-Hyun, et al.
Publicado: (2019)

First Report of Ventriculoperitoneal Shunt Infection due to Cyberlindnera fabianii
por: Baghdadi, Jonathan, et al.
Publicado: (2015)

Multiple organ dysfunction syndrome and death secondary to Cyberlindnera fabianii
por: Desai, Mehul, et al.
Publicado: (2019)

Total transcriptome analysis of Candida auris planktonic cells exposed to tyrosol
por: Balla, Noémi, et al.
Publicado: (2023)

In Vivo Efficacy of Amphotericin B against Four Candida auris Clades
por: Forgács, Lajos, et al.
Publicado: (2022)

Synergistic Interaction of Caspofungin Combined with Posaconazole against FKS Wild-Type and Mutant Candida auris Planktonic Cells and Biofilms
por: Balla, Noémi, et al.
Publicado: (2022)

A pseudo-outbreak of Cyberlindnera fabianii funguria: Implication from whole genome sequencing assay
por: Fan, Xin, et al.
Publicado: (2023)

Genome Sequences of Cyberlindnera fabianii 65, Pichia kudriavzevii 129, and Saccharomyces cerevisiae 131 Isolated from Fermented Masau Fruits in Zimbabwe
por: van Rijswijck, Irma M. H., et al.
Publicado: (2017)

Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against Candida Species
por: Tóth, Zoltán, et al.
Publicado: (2020)

Unpredictable In Vitro Killing Activity of Amphotericin B against Four Candida auris Clades
por: Papp, Zoltán, et al.
Publicado: (2021)

Unequivocal identification of an underestimated opportunistic yeast species, Cyberlindnera fabianii, and its close relatives using a dual-function PCR and literature review of published cases
por: Arastehfar, Amir, et al.
Publicado: (2019)

In Vitro Killing Activities of Anidulafungin and Micafungin with and without Nikkomycin Z against Four Candida auris Clades
por: Adnan, Awid, et al.
Publicado: (2023)

The Effect on Mortality of Fluconazole or Echinocandins Treatment in Candidemia in Internal Medicine Wards
por: De Rosa, Francesco G., et al.
Publicado: (2015)

Mutants with heteroresistance to amphotericin B and fluconazole in Candida
por: Claudino, A.L.R., et al.
Publicado: (2009)

Follow-up Study of Microflora Changes in Crevicular Gingival Fluid in Obese Subjects After Bariatric Surgery
por: Balogh, Bettina, et al.
Publicado: (2020)

Correction: The Effect on Mortality of Fluconazole or Echinocandins Treatment in Candidemia in Internal Medicine Wards
Publicado: (2015)

2117. Fluconazole vs. Echinocandins as Initial Therapy for Candidemia Caused by Fluconazole-Susceptible Species in the Era of Rapid Diagnostic Testing
por: Roshdy, Danya, et al.
Publicado: (2019)

Application of caspofungin in China compared with amphotericin B and fluconazole
por: Zhang, Chunyu, et al.
Publicado: (2014)

Amphotericin-b/fluconazole: Lack of efficacy: case report
Publicado: (2021)

Amphotericin-b/fluconazole: Lack of efficacy: case report
Publicado: (2022)

Biofilm Formation and Susceptibility to Amphotericin B and Fluconazole in Candida albicans
por: Zarei Mahmoudabadi, Ali, et al.
Publicado: (2014)

Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients
por: Grau, S, et al.
Publicado: (2015)

Post-antifungal effect of the combination of anidulafungin with amphotericin B and fluconazole against fluconazole-susceptible and -resistant Candida albicans
por: Vaseghi, Narges, et al.
Publicado: (2022)

In vitro and in vivo Effect of Exogenous Farnesol Exposure Against Candida auris
por: Nagy, Fruzsina, et al.
Publicado: (2020)

Effects of environmental factors on sensitivity of Cryptococcus neoformans to fluconazole and amphotericin B
por: Carlson, Tyler, et al.
Publicado: (2021)

Expanding the Knowledge on the Skillful Yeast Cyberlindnera jadinii
por: Sousa-Silva, Maria, et al.
Publicado: (2021)

Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis
por: Prépost, Eszter, et al.
Publicado: (2019)

Comparison of In Vitro Killing Activity of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Candida auris Clades in RPMI-1640 in the Absence and Presence of Human Serum
por: Kovács, Renátó, et al.
Publicado: (2021)

Pichia fabianii blood infection in a premature infant in China: case report
por: Wu, Yuan, et al.
Publicado: (2013)

Comparison of in vivo pathogenicity of four Candida auris clades in a neutropenic bloodstream infection murine model
por: Forgács, Lajos, et al.
Publicado: (2020)

Drug susceptibility in emerging fungal infections: tests with fluconazole, itraconazole, and amphotericin B
por: Fay, Vanessa da Silva, et al.
Publicado: (2018)

Antiphagocytic protein 1 increases the susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole
por: Ghaffar, Muhammad, et al.
Publicado: (2019)

Susceptibility testing of Candida albicans isolated from oropharyngeal mucosa of HIV(+) patients to fluconazole, amphotericin B and Caspofungin. killing kinetics of caspofungin and amphotericin B against fluconazole resistant and susceptible isolates
por: de Aquino Lemos, Janine, et al.
Publicado: (2009)

Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies
por: Moreno-García, E, et al.
Publicado: (2021)

In vitro activity of rezafungin against common and rare Candida species and Saccharomyces cerevisiae
por: Tóth, Zoltán, et al.
Publicado: (2019)

929 Comparison of Echinocandin vs Amphotericin B Based Therapy for Candida Infective Endocarditis: An Observational Cohort Study
por: Arnold, Christopher, et al.
Publicado: (2014)

The Neosartorya fischeri Antifungal Protein 2 (NFAP2): A New Potential Weapon against Multidrug-Resistant Candida auris Biofilms
por: Kovács, Renátó, et al.
Publicado: (2021)

P031 Post-antifungal effect of the combination of a nidulafungin with amphotericin B and fluconazole against fluconazole-susceptible and resistant Candida albicans
por: Aslani, Narges
Publicado: (2022)

The trend of susceptibilities to amphotericin B and fluconazole of Candida species from 1999 to 2002 in Taiwan
por: Yang, Yun-Liang, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_5r83uv8oprp4mauj0geff0ieh9